Eli Lilly & Co. (LLY) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Pfizer Inc. (PFE), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- Merck & Co. Inc. (MRK), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Abbott Laboratories (ABT), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- Novo Nordisk A/S (NVO), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- AstraZeneca PLC (AZN), Common-Size Liabilities and Stockholders' Equity
- Medtronic Inc. (MDT), Common-Size Liabilities and Stockholders' Equity
- Baxter International Inc. (BAX), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Eli Lilly & Co., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Short-term borrowings and current maturities of long-term debt | |
|
|
|
|
|
Accounts payable | |
|
|
|
|
|
Employee compensation | |
|
|
|
|
|
Sales rebates and discounts | |
|
|
|
|
|
Dividends payable | |
|
|
|
|
|
Income taxes payable | |
|
|
|
|
|
Other current liabilities | |
|
|
|
|
|
Current liabilities | % |
% |
% |
% |
% |
|
Long-term debt, excluding current maturities | |
|
|
|
|
|
Accrued retirement benefits | |
|
|
|
|
|
Long-term income taxes payable | |
|
|
|
|
|
Other noncurrent liabilities | |
|
|
|
|
|
Other liabilities | % |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
|
Common stock, no par value | |
|
|
|
|
|
Additional paid-in capital | |
|
|
|
|
|
Retained earnings | |
|
|
|
|
|
Employee benefit trust | |
|
|
|
|
|
Deferred costs, ESOP | |
|
|
|
|
|
Accumulated other comprehensive income (loss) | |
|
|
|
|
|
Cost of common stock in treasury | |
|
|
|
|
|
Shareholders’ equity attributable to parent | % |
% |
% |
% |
% |
|
Noncontrolling interests | |
|
|
|
|
|
Total shareholders’ equity | % |
% |
% |
% |
% |
|
Total liabilities and shareholders’ equity | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center